6667 — Mega Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Mega Genomics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	208	239	400	518	490
Net Total Accounts Receivable
Net Total Receivables	131	204	191	120	90.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	358	685	619	668	626
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	62.2	51.1	46.9	94	79.3
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	454	772	706	797	738
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	262	69.8	81.2	114	90.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	277	77.7	87.7	152	124
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	176	694	618	645	615
Total Liabilities & Shareholders' Equity	454	772	706	797	738
Total Common Shares Outstanding